Engineered Bacteria May Improve Precision Cancer Drug Delivery
Engineered Escherichia coli Nissle 1917 produced and delivered an FDA-approved anticancer drug directly inside tumors in mice, showing promise for targeted cancer therapy.
4 Articles
4 Articles
Scientists Turn Bacteria Into Tiny Tumor Hunters That Kill Cancer
Scientists turned bacteria into tumor-hunting drug factories—hinting at a bold new way to fight cancer. Millions of people worldwide are diagnosed with cancer each year, yet treating the disease remains challenging due to its complexity. New research published today (March 17) in the open-access journal PLOS Biology by Tianyu Jiang at Shandong University in Qingdao, [...]
Genetically Engineered Bacteria Target Tumors to Directly Deliver Cancer
In a groundbreaking advance that could reshape the future of oncology, researchers at Shandong University in Qingdao, China, have successfully engineered a probiotic bacterium, Escherichia coli Nissle 1917 (EcN), to biosynthesize and deliver an FDA-approved anticancer drug directly to tumor cells. This innovative strategy, detailed in a recent publication in PLOS Biology, combines cutting-edge synthetic […]
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium

